A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of ...

Institutions that are not genuinely serving the underserved should not collect 340B discounts, and the loopholes that reward ...

Hospital drug markups are in the crosshairs as a new proposal targets 340B facilities where a $700 prostate cancer treatment ...

The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual ...

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...

A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning whether those savings are being used ...

Outpatient drug purchases under the 340B Drug Pricing Program crossed the $100 billion mark across 2025, a roughly 23% ...

This spring, Minnesota state lawmakers are considering legislation (SF 3769/HF 3609) to further enforce compliance with the 340B program, which allows qualifying medical facilities to buy medications ...

​A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to ...

“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...

AHA responds to Information Collection Request about the Health Resources and Services Administration’s proposed 340B Rebate Model Program.